Drug Shortage Report for RISEDRONATE
Report ID | 190325 |
Drug Identification Number | 02411407 |
Brand name | RISEDRONATE-35 |
Common or Proper name | Risedronate |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | RISEDRONATE SODIUM |
Strength(s) | 35MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 4 |
ATC code | M05BA |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-01-23 |
Estimated end date | 2024-02-16 |
Actual end date | 2024-02-16 |
Shortage status | Resolved |
Updated date | 2024-02-17 |
Company comments | Long-term shortage |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2024-02-17 | English | Compare |
v4 | 2024-02-02 | French | Compare |
v3 | 2024-02-02 | English | Compare |
v2 | 2023-04-26 | French | Compare |
v1 | 2023-04-26 | English | Compare |
Showing 1 to 5 of 5